Biogen R&D Veteran Joins AI Drug Company
A former Biogen leader, Dr. Michael Ehlers, now guides research at AI-focused drug developer, Formation Bio.
Dr. Michael Ehlers joins Formation Bio as Chief Scientific Officer. He will also lead research and development. Dr. Ehlers brings strong experience to the company. He worked at Biogen, a big name in biotech, for many years.
Formation Bio uses artificial intelligence to make new medicines. This company is growing fast. FierceBiotech named Formation Bio a "Fierce 15" company to watch in 2025.
Dr. Ehlers has worked in biotech, big pharmaceutical companies, and universities. This deep knowledge helps Formation Bio. He will help the company find and create new drugs.
This move shows AI's growing role in finding treatments. Expert leaders like Dr. Ehlers are moving to companies that use new technology. This can speed up how new medicines reach patients.
Source: FierceBiotech
More from Biotech
